Article
Landscape of NAT2 polymorphisms among breast cancer.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie - 1 Feb 2016
Wang Tengfei, Marei Hany E
Abstract excerpt
PURPOSE: The prevalence of phenotypes of Arylamine N-acetyltransferase-2(NAT2) gene (i.e. fast, intermediate and slow acetylators) among ethnic groups, as well as the association studies regarding NAT2 polymorphisms and risk of breast cancer produced inconsistent results. This meta-analysis aimed to clarify whether the selected NAT2 phenotypes have an effect on the susceptibility to breast cancer. METHODS: After...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
